265 related articles for article (PubMed ID: 29273915)
21. Cyclin D1 (CCND1) messenger RNA expression as assessed by real-time PCR contributes to diagnosis and follow-up control in patients with mantle cell lymphoma.
Bacher U; Kern W; Haferlach C; Alpermann T; Haferlach T; Schnittger S
Exp Hematol; 2013 Dec; 41(12):1028-37. PubMed ID: 24060591
[TBL] [Abstract][Full Text] [Related]
22. Determination of cyclin D1 and CD20 mRNA levels by real-time quantitative RT-PCR from archival tissue sections of mantle cell lymphoma and other non-Hodgkin's lymphomas.
Thomázy VA; Luthra R; Uthman MO; Davies PJ; Medeiros LJ
J Mol Diagn; 2002 Nov; 4(4):201-8. PubMed ID: 12411587
[TBL] [Abstract][Full Text] [Related]
23. Quantitation of cyclin D1 over-expression using competitive fluorescent reverse transcription polymerase chain reaction: a tool for the differential diagnosis of mantle cell lymphoma.
Wickham CL; Armitage H; Joyner MV; Sarsfield P; Boyce M; Wilkins BS; Jones DB; Ellard S
Med Oncol; 2003; 20(1):77-85. PubMed ID: 12665688
[TBL] [Abstract][Full Text] [Related]
24. Immunoglobulin kappa deleting element rearrangements are candidate targets for minimal residual disease evaluation in mantle cell lymphoma.
Della Starza I; De Novi LA; Cavalli M; Novelli N; Soscia R; Genuardi E; Mantoan B; Drandi D; Ferrante M; Monitillo L; Barbero D; Ciabatti E; Grassi S; Bomben R; Degan M; Gattei V; Galimberti S; Di Rocco A; Martelli M; Cortelazzo S; Guarini A; Foà R; Ladetto M; Ferrero S; Del Giudice I;
Hematol Oncol; 2020 Dec; 38(5):698-704. PubMed ID: 32816326
[TBL] [Abstract][Full Text] [Related]
25. Blastic mantle cell leukemia: an unusual presentation of blastic mantle cell lymphoma.
Viswanatha DS; Foucar K; Berry BR; Gascoyne RD; Evans HL; Leith CP
Mod Pathol; 2000 Jul; 13(7):825-33. PubMed ID: 10912944
[TBL] [Abstract][Full Text] [Related]
26. Analysis of cyclin D1 expression by quantitative real-time reverse transcription-polymerase chain reaction in the diagnosis of mantle cell lymphoma.
Peghini PE; Fehr J
Am J Clin Pathol; 2002 Feb; 117(2):237-45. PubMed ID: 11863220
[TBL] [Abstract][Full Text] [Related]
27. Cyclin D1-negative mantle cell lymphoma: a clinicopathologic study based on gene expression profiling.
Fu K; Weisenburger DD; Greiner TC; Dave S; Wright G; Rosenwald A; Chiorazzi M; Iqbal J; Gesk S; Siebert R; De Jong D; Jaffe ES; Wilson WH; Delabie J; Ott G; Dave BJ; Sanger WG; Smith LM; Rimsza L; Braziel RM; Müller-Hermelink HK; Campo E; Gascoyne RD; Staudt LM; Chan WC;
Blood; 2005 Dec; 106(13):4315-21. PubMed ID: 16123218
[TBL] [Abstract][Full Text] [Related]
28. Quantitative real-time reverse transcription-PCR assay for cyclin D1 expression: utility in the diagnosis of mantle cell lymphoma.
Bijwaard KE; Aguilera NS; Monczak Y; Trudel M; Taubenberger JK; Lichy JH
Clin Chem; 2001 Feb; 47(2):195-201. PubMed ID: 11159766
[TBL] [Abstract][Full Text] [Related]
29. CD5-undetected by immunohistochemistry, t(11;14)(q13;q32)-positive conjunctival mantle cell lymphoma: a case report.
Yoo SB; Kim YA; Jeon YK; Kim CW
Pathol Res Pract; 2008; 204(10):779-83. PubMed ID: 18572329
[TBL] [Abstract][Full Text] [Related]
30. Pleomorphic mantle cell lymphoma morphologically mimicking diffuse large B cell lymphoma: common cyclin D1 negativity and a simple immunohistochemical algorithm to avoid the diagnostic pitfall.
Chuang WY; Chang H; Chang GJ; Wang TH; Chang YS; Wang TH; Yeh CJ; Ueng SH; Chien HP; Chang CY; Wan YL; Hsueh C
Histopathology; 2017 May; 70(6):986-999. PubMed ID: 28032914
[TBL] [Abstract][Full Text] [Related]
31. Differential expression of cyclin D1 in mantle cell lymphoma and other non-Hodgkin's lymphomas.
Aguilera NS; Bijwaard KE; Duncan B; Krafft AE; Chu WS; Abbondanzo SL; Lichy JH; Taubenberger JK
Am J Pathol; 1998 Dec; 153(6):1969-76. PubMed ID: 9846986
[TBL] [Abstract][Full Text] [Related]
32.
Martín-Garcia D; Navarro A; Valdés-Mas R; Clot G; Gutiérrez-Abril J; Prieto M; Ribera-Cortada I; Woroniecka R; Rymkiewicz G; Bens S; de Leval L; Rosenwald A; Ferry JA; Hsi ED; Fu K; Delabie J; Weisenburger D; de Jong D; Climent F; O'Connor SJ; Swerdlow SH; Torrents D; Beltran S; Espinet B; González-Farré B; Veloza L; Costa D; Matutes E; Siebert R; Ott G; Quintanilla-Martinez L; Jaffe ES; López-Otín C; Salaverria I; Puente XS; Campo E; Beà S
Blood; 2019 Feb; 133(9):940-951. PubMed ID: 30538135
[TBL] [Abstract][Full Text] [Related]
33. Mantle cell lymphomas with low levels of cyclin D1 long mRNA transcripts are highly proliferative and can be discriminated by elevated cyclin A2 and cyclin B1.
Sander B; Flygare J; Porwit-Macdonald A; Smith CI; Emanuelsson E; Kimby E; Liden J; Christensson B
Int J Cancer; 2005 Nov; 117(3):418-30. PubMed ID: 15900590
[TBL] [Abstract][Full Text] [Related]
34. [Detection of cyclin D1 mRNA by reverse transcription-polymerase chain reaction in paraffin-embedded tissues and its diagnostic significance for mantle cell lymphoma].
Shui RH; Wei YK; Sun MH; Wang J; Shi DR; Zhang TM; Jin AP; Zhu XZ
Zhonghua Bing Li Xue Za Zhi; 2005 Aug; 34(8):514-8. PubMed ID: 16383299
[TBL] [Abstract][Full Text] [Related]
35. Blastoid variant of mantle cell lymphoma: late progression from classical mantle cell lymphoma and quantitation of minimal residual disease.
Pott C; Schrader C; Brüggemann M; Ritgen M; Harder L; Raff T; Tiemann M; Dreger P; Kneba M
Eur J Haematol; 2005 Apr; 74(4):353-8. PubMed ID: 15777349
[TBL] [Abstract][Full Text] [Related]
36. Four human t(11;14)(q13;q32)-containing cell lines having classic and variant features of Mantle Cell Lymphoma.
Tucker CA; Bebb G; Klasa RJ; Chhanabhai M; Lestou V; Horsman DE; Gascoyne RD; Wiestner A; Masin D; Bally M; Williams ME
Leuk Res; 2006 Apr; 30(4):449-57. PubMed ID: 16183118
[TBL] [Abstract][Full Text] [Related]
37. Molecular Monitoring after Autologous Stem Cell Transplantation and Preemptive Rituximab Treatment of Molecular Relapse; Results from the Nordic Mantle Cell Lymphoma Studies (MCL2 and MCL3) with Median Follow-Up of 8.5 Years.
Kolstad A; Pedersen LB; Eskelund CW; Husby S; Grønbæk K; Jerkeman M; Laurell A; Räty R; Elonen E; Andersen NS; Brown PD; Kimby E; Bentzen H; Sundström C; Ehinger M; Karjalainen-Lindsberg ML; Delabie J; Ralfkiær E; Fagerli UM; Nilsson-Ehle H; Lauritzsen GF; Kuittinen O; Niemann C; Geisler CH;
Biol Blood Marrow Transplant; 2017 Mar; 23(3):428-435. PubMed ID: 28039078
[TBL] [Abstract][Full Text] [Related]
38. Quantitative measurement of cyclin D1 mRNA, a potent diagnostic tool to separate mantle cell lymphoma from other B-cell lymphoproliferative disorders.
Brizova H; Kalinova M; Krskova L; Mrhalova M; Kodet R
Diagn Mol Pathol; 2008 Mar; 17(1):39-50. PubMed ID: 18303407
[TBL] [Abstract][Full Text] [Related]
39. CCND2 rearrangements are the most frequent genetic events in cyclin D1(-) mantle cell lymphoma.
Salaverria I; Royo C; Carvajal-Cuenca A; Clot G; Navarro A; Valera A; Song JY; Woroniecka R; Rymkiewicz G; Klapper W; Hartmann EM; Sujobert P; Wlodarska I; Ferry JA; Gaulard P; Ott G; Rosenwald A; Lopez-Guillermo A; Quintanilla-Martinez L; Harris NL; Jaffe ES; Siebert R; Campo E; Beà S
Blood; 2013 Feb; 121(8):1394-402. PubMed ID: 23255553
[TBL] [Abstract][Full Text] [Related]
40. Targeted locus amplification to detect molecular markers in mantle cell and follicular lymphoma.
Genuardi E; Klous P; Mantoan B; Drandi D; Ferrante M; Cavallo F; Alessandria B; Dogliotti I; Grimaldi D; Ragaini S; Clerico M; Lo Schirico M; Saraci E; Yilmaz M; Zaccaria GM; Cortelazzo S; Vitolo U; Luminari S; Federico M; Boccadoro M; van Min M; Splinter E; Ladetto M; Ferrero S
Hematol Oncol; 2021 Aug; 39(3):293-303. PubMed ID: 33742718
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]